Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024 - PowerPoint PPT Presentation

About This Presentation

Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024


Get more details @ Few players dominate clinical nutrition market such as Abbott Laboratories, Nestle, Danone, Fresenius Kabi, Hospira, Perrigo, B Braun Melsungen, Baxter International and Mead Johnson. Product development, strategic alliances and consolidating across the distribution channel remain key commercial strategies adopted by industry participants. Industry participants are also expanding their operations in emerging economies to gain extended market access and strengthen their market position. – PowerPoint PPT presentation

Number of Views:76


Transcript and Presenter's Notes

Title: Clinical Nutrition Market to grow at 7% CAGR from 2017 to 2024

Global Clinical Nutrition Market to surpass 80
billion by 2024
Fuel Cell Market size worth 25.5bn by 2024
Key Insights of Clinical Nutrition Market
  • The growing geriatric population, rise in the
    number of metabolic disorders, and an increase in
    the number of premature births are key factors
    that will propel clinical nutrition market, which
    was worth USD 40 billion in 2015, and will grow
    at a CAGR of 7 over 2017-2024.
  • The world is witnessing a rise in the number of
    disorders subject to the lack of proper
    nutrition, as per scientists.
  • Clinical nutrition market is controlled by a
    specific number of leading players accounting for
    a major share.
  • Pertaining to the growth of clinical nutritional
    market in India and China, APAC is likely to
    experience a massive growth over the years ahead.
  • Infant products accounted for more than 55 of
    clinical nutrition market in 2015, and is likely
    to grow at a CAGR of 9 over 2017-2024.
  • Milk based infant products contributed to more
    than 70 of infant clinical nutrition industy
    share in 2015, and will cross a revenue of more
    than USD 35 billion by 2024, subject to the
    rising inclination toward tasty, tolerant,
    healthy milk-based nutritional products for

  • Parenteral nutritional products are fairly
    prominent in the product landscape of clinical
    nutrition market, having held a valuation of more
    than USD 4.2 billion in 2015.
  • Amino acids accounted for more than 40 of
    parenteral clinical nutrition market share in
    2015 and will grow substantially over 2017-2024,
    subject to the fact that they effectively help
    address the body metabolism issues.
  • In 2015, U.S. clinical nutrition market size was
    worth more than USD 8 billion, and will grow at a
    rate of 6 over 2017-2024.
  • In 2015, UK accounted for more than 17 of Europe
    clinical nutrition market share, subject to the
    increasing disposable incomes of patients and the
    rising expenditure on healthcare.
  • Companies such as Hospira, Baxter International,
    Danone, B Braun Melsungen, Nestle, Mead Johnson,
    Perrigo, Fresenius Kabi, Abbott Laboratories, and
    H. J. Heinz mainly operate in this industry, and
    are engaged in tried-and-tested as well as
    innovative growth strategies to expand their
    business and provide a competitive edge to their

Europe Clinical Nutrition Market, By Product,
2012 - 2024 (USD Million)


Browse Full Market Research Report of Clinical
Nutrition Market _at_ http//
Request for a Sample of this Research
report _at_ https//
Table of Contents
Chapter 1. Methodology Scope 1.1  Research
Methodology                    1.1.1 Initial
data exploration       1.1.2 Statistical model
and forecast        1.1.3 Industry insights and
validation      1.1.4 Market definition and
forecast parameters 1.2 Data Sources              
        1.2.1 Primary     1.2.2
Secondary             Chapter 2. Executive
Summary 2.1  Clinical Nutrition industry 3600
synopsis, 2012 - 2024             2.1.1 Business
trends    2.1.2 Product trends      2.1.3
Regional trends    Chapter 3. Clinical Nutrition
Industry Insights 3.1 Industry segmentation       
               3.2 Industry size forecast, 2012
- 2024 3.3 Industry ecosystem analysis 3.3.1
Distribution channel analysis          3.4
Industry impact forces                     
3.4.1 Growth Drivers Increasing
metabolic disorders and other chronic
diseases Junk food habits leading to
malnourishment in U.S. Europe
Increasing geriatric population
Increasing rate of pre-mature birth birth rate
in APAC Increasing adoption of home
healthcare in North America and Europe 3.4.2
Industry pitfalls Challenges
Stringent government regulations in U.S., Europe,
and APAC Lack of awareness regarding
nutrition in developing countries 3.5 Growth
potential analysis                 3.6 Regulatory
landscape                      3.6.1
U.S.         3.6.2 Europe     3.6.3
China        3.7 Reimbursement scenario 3.7.1
U.S. 3.7.2 Europe 3.8 Pipeline analysis
3.9 Pricing analysis 3.9.1 North America 3.9.2
Europe 3.9.3 Asia Pacific 3.9.4 Latin
America 3.9.5 MEA 3.10 Volume analysis 3.10.1
North America 3.10.2 Europe 3.10.3
Asia-Pacific 3.10.4 Latin-America 3.10.5 Middle
East Africa 3.11 Patent Landscape 3.11.1
Infant nutrition 3.11.2 Enteral
Nutrition 3.11.3 Parenteral nutrition 3.12
Porter's Analysis                3.13 PESTEL
Analysis   3.14 Company market share analysis,
2016 3.14.1. Revenue 3.14.2. Product
landscape 3.14.2. Strategic landscape
Stay In Touch Website https//
Social Media
Write a Comment
User Comments (0)